IHS Chemical Week

Markets :: Specialty Chemicals :: Personal Care

Ashland beats estimates but abandons 2014 targets

2:20 PM MDT | April 24, 2013 | Vincent Valk

Ashland today reported fiscal second-quarter net income down 39.8% year-on-year (YOY), to $53 million, or 68 cts/share, on sales down 5.3%, to $1.97 billion. The quarter, however, included a number of charges related to a restructuring of debt obligations. Excluding these charges, adjusted net income from continuing operations was up 17%, to $1.78/share, easily beating analysts’ consensus of $1.54/share, as reported by Thomson Reuters.   The company, however, has abandoned its 2014 earning guidance because of unexpectedly weak economic conditions...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa